The response to vaccination against influenza A(H1N1) 2009, seasonal influenza andStreptococcus pneumoniaein adult outpatients with ongoing treatment for cancer with and without rituximab

Immunogenicity of an Inactivated Monovalent 2009 Influenza A (H1N1) Vaccine in Patients Who Have Cancer

(2012) Y. Xu et al.   ONCOLOGIST

A Prospective Study of the Factors Shaping Antibody Responses to the AS03-Adjuvanted Influenza A/H1N1 Vaccine in Cancer Outpatients

(2012) A. F. Hottinger et al.   ONCOLOGIST

Response to influenza virus vaccination during chemotherapy in patients with breast cancer

(2011) A. Meerveld-Eggink et al.   ANNALS OF ONCOLOGY

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study

(2011) B. Rousseau et al.   ANNALS OF ONCOLOGY

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

(2011) O. E. Yri et al.   BLOOD

Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study

(2011) P Loulergue et al.   BRITISH JOURNAL OF CANCER

Why it is still important that countries know the burden of pneumococcal disease

(2011) Rosa Prato et al.   Human vaccines & immunotherapeutics

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis

(2011) J. Kevin Yin et al.   Influenza and Other Respiratory Viruses

Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens

(2011) D. Bedognetti et al.   JOURNAL OF IMMUNOLOGY

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

(2010) Angel Vila-Corcoles et al.   BMC INFECTIOUS DISEASES

Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment

(2010) Helen J. Mackay et al.   JOURNAL OF CLINICAL VIROLOGY

Mechanisms and resistance in glucocorticoid control of inflammation

(2010) Peter J. Barnes   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay

(2009) Heleen Borgers et al.   CLINICAL IMMUNOLOGY

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

(2009) Ken M Kunisaki et al.   LANCET INFECTIOUS DISEASES

The Persistent Legacy of the 1918 Influenza Virus

(2009) David M. Morens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial

(2009) François Roman et al.   VACCINE

Low influenza vaccination rate among patients receiving chemotherapy for cancer

(2008) P. Loulergue et al.   ANNALS OF ONCOLOGY